No significant side effects reported.
As Anhydrous Calcium Acetate is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Anhydrous Calcium Acetate for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Anhydrous Calcium Acetate could have any negative effects on these vulnerable groups. It should be safe to use Anhydrous Calcium Acetate in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Anhydrous Calcium Acetate for long period in food for newborns or pregnant.
Generally recognized as safe(GRAS) is a FDA designation that a specific substance or ingredient is generally considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Anhydrous Calcium Acetate is considered safe by FDA according to existing data and granted GRAS status.
No breaking news or public health crises reported about Anhydrous Calcium Acetate reported up to now.
* Want to report news about this ingredient, please send email to foodchemmis08@foodchem.cn. Your knowledge can help us to uncover more truthes about food ingredients to customers.
1. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis [Nephrol Dial Transplant. 2009 Jan]
Author: Evenepoel P, Selgas R, Caputo F, Foggensteiner L, Heaf JG, Ortiz A, Kelly A, Chasan-Taber S, Duggal A, Fan S.
2. Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in medicare part d. [Am J Kidney Dis. 2014 Jul]
Author: Yusuf AA, Weinhandl ED, St Peter WL.
3. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. [Nephrol Dial Transplant. 2013 Sep]
Author: Covic A, Passlick-Deetjen J, Kroczak M, Büschges-Seraphin B, Ghenu A, Ponce P, Marzell B, de Francisco AL.
4. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. [Am J Kidney Dis. 2012 Feb]
Author: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C.
5. Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease. [Indian J Pharmacol. 2009 Aug]
Author: Scaria PT, Gangadhar R, Pisharody R.